Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Total Debt came in at $82654.9 in Q4 2025, down 17.53% on a QoQ basis from $100230.1 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Total Debt data on file, last reported at $82654.9 in Q4 2025.
- Quarterly Total Debt changed N/A year-over-year to $82654.9 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $82654.9 (changed N/A YoY) and the FY2025 annual result came in at $100321.9, down 76.48% from the prior year.
- Total Debt eased to $82654.9 in Q4 2025, from $100230.1 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $426507.1 in Q2 2024 to a low of $82654.9 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.72 Bn | 196.12 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 126.49 Bn | 123.01 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 119.21 Bn | 109.99 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 73.88 Bn | 73.35 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.71 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.81 Bn | 32.86 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.29 Bn | 22.97 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.13 Mn | 4.09 Mn | - | 82,654.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 82,654.94 |
| Apr 30, 2025 | 100,230.11 |
| Apr 30, 2024 | 426,507.07 |